CVS Health Corporation ($CVS) Stock Forecast: Down 5.1% Today

What is CVS Health Corporation?

CVS Health (CVS) is a notable healthcare company that runs pharmacies and healthcare benefits services. Market sentiment towards CVS has been negative today.

Why is CVS Health Corporation going down?

CVS stock is down 5.1% on Jul 24, 2025 19:56

• Despite the anticipation of surpassing earnings expectations and encouraging indications of a possible revival, CVS stock faced a significant downtrend.
• The decrease in Q2 earnings predictions and worries regarding the company's performance might have overshadowed the positive developments, contributing to the market's bearish movement.
• Investors could have responded unfavorably to the uncertainties surrounding CVS's future performance, notwithstanding the company's efforts to enhance its Health Care Benefits division and potential signs of a turnaround.
• Despite the stock being technically oversold and receiving favorable evaluations from analysts, these factors may not have been sufficient to counterbalance the existing concerns, resulting in CVS's bearish trajectory today.

CVS Price Chart

CVS Technical Analysis

CVS News

CVS or DHR: Which Is the Better Value Stock Right Now?

CVS vs. DHR: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2613118/cvs-or-dhr-which-is-the-better-value-stock-right-now

CVS Health ( CVS ) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

https://www.zacks.com/stock/news/2612609/cvs-health-cvs-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q2-release

CVS Q2 Estimates Dip: Is the Stock Still a Buy Ahead of Q2 Earnings?

Earnings estimates for CVS dip ahead of Q2 results, but turnaround efforts in Aetna and PBM strength may offset pressure.

https://www.zacks.com/stock/news/2608988/cvs-q2-estimates-dip-is-the-stock-still-a-buy-ahead-of-q2-earnings

What's Shaping CVS' Health Care Benefits Arm for the Rest of 2025?

CVS Health's Health Care Benefits arm posts solid Medicare gains and prepares for an ACA exit with a $448M reserve.

https://www.zacks.com/stock/news/2606959/whats-shaping-cvs-health-care-benefits-arm-for-the-rest-of-2025

Here's Why CVS Health ( CVS ) is Poised for a Turnaround After Losing 7.7% in 4 Weeks

CVS Health (CVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

https://www.zacks.com/stock/news/2603125/heres-why-cvs-health-cvs-is-poised-for-a-turnaround-after-losing-77-in-4-weeks

Trending Today

Upstart Holdings Inc. ($UPST) Stock Forecast: Down 6.8% Today

Astera Labs Inc ($ALAB) Stock Forecast: Down 5.8% Today

Rivian Automotive Inc. ($RIVN) Stock Forecast: Down 5.2% Today

Johnson Controls International plc ($JCI) Stock Forecast: Down 7.7% Today

Eli Lilly and Company ($LLY) Stock Forecast: Down 5.2% Today

Petco Health and Wellness Co. Inc. ($WOOF) Stock Forecast: Down 5.1% Today

United Parcel Service Inc. ($UPS) Stock Forecast: Down 10.6% Today

Lucid Motors Inc. ($LCID) Stock Forecast: Down 7.9% Today

UnitedHealth Group Incorporated (DE) ($UNH) Stock Forecast: Down 6.3% Today

Welltower Inc. ($WELL) Stock Forecast: Up 5.2% Today

CVS Health Corporation Price History

17.03.2025 - CVS Stock was down 7.2%

• CVS stock saw a decline of -0.55% and -1.87% in recent trading sessions.
• A comparison between CVS Health and UnitedHealth may have influenced investors' decisions, leading to some selling pressure on CVS stock.
• Uncertainty around healthcare policies and regulations may have also affected the bearish trend in CVS stock.
• Monitoring upcoming developments in the healthcare sector is crucial for investors to gauge the performance of CVS Health stock.

24.06.2025 - CVS Stock was down 5.1%

• Despite the anticipation of surpassing earnings expectations and encouraging indications of a possible revival, CVS stock faced a significant downtrend.
• The decrease in Q2 earnings predictions and worries regarding the company's performance might have overshadowed the positive developments, contributing to the market's bearish movement.
• Investors could have responded unfavorably to the uncertainties surrounding CVS's future performance, notwithstanding the company's efforts to enhance its Health Care Benefits division and potential signs of a turnaround.
• Despite the stock being technically oversold and receiving favorable evaluations from analysts, these factors may not have been sufficient to counterbalance the existing concerns, resulting in CVS's bearish trajectory today.

01.04.2025 - CVS Stock was up 6.9%

• CVS Health outperformed expectations in the first quarter, prompting an increase in its full-year EPS guidance, which in turn boosted its stock value.
• A partnership with Novo Nordisk to improve access to Wegovy, a weight loss treatment, for CVS drug plan members played a role in boosting investor confidence.
• The company's strong financial results, highlighted by a sharp increase in adjusted EPS and operating income, bolstered the upward momentum of the stock.
• The market's positive reaction demonstrates faith in CVS's strategies and financial performance, leading to upward movement in the stock price even amidst market volatility.

01.04.2025 - CVS Stock was up 9.7%

• CVS Health (CVS) saw a notable upward movement in trading today.
• The company's Q1 earnings and revenues surpassed market expectations by a substantial margin, which likely instilled confidence among investors.
• The decision to prioritize Novo Nordisk's weight loss treatment Wegovy on its formulary may have also contributed to the positive market sentiment, hinting at potential growth avenues and improved healthcare offerings.
• Analysts' positive projections for CVS Health's earnings growth, along with the anticipation of a robust earnings performance, may have additionally bolstered the bullish momentum, attracting increased investor interest in the stock.

02.04.2025 - CVS Stock was down 4.4%

• CVS Health reported better-than-expected first-quarter results and raised its FY25 EPS guidance, leading to a sharp rise in its stock price.
• The partnership with Wegovy maker Novo Nordisk and the significant improvement in adjusted EPS and operating income contributed to the positive market sentiment towards CVS.
• The earnings and revenue beats in Q1 2025, along with the raised EPS view, further fueled investor confidence in CVS Health, driving the stock price higher.
• Despite the positive news and strong financial performance, the market might have reacted bearishly due to profit-taking or broader market factors impacting CVS's stock price negatively.

13.04.2025 - CVS Stock was down 5.2%

• The decline in CVS stock value could be linked to a recent executive order that aims to align U.S. drug prices with those of other countries, potentially impacting the company's financial performance.
• Although there were positive sentiments in options trading, the general market outlook has shifted negatively, resulting in the drop in CVS stock.
• Glenview Capital's remarks about CVS Health's progress in its long-term transformation might have been overshadowed by broader market anxieties, contributing to the stock's downturn.
• Investor perception of CVS Health compared to other industry peers may have also played a role in the stock price decrease.

13.04.2025 - CVS Stock was down 7.0%

• The bearish movement in CVS stock today could be attributed to investors potentially favoring Danaher (DHR) over CVS as a better value option in the Medical Services sector.
• Glenview Capital's statement on CVS Health may have failed to reassure investors about the company's long-term turnaround plans, leading to a lack of confidence in CVS stock.
• The overall sentiment in the market towards healthcare stocks might have also contributed to the bearish movement in CVS, as investors may be cautious about regulatory impacts and competitive pressures in the sector.

08.03.2025 - CVS Stock was up 8.7%

• CVS Health's recent appointment of a new CFO, along with strong Q4 sales that surpassed expectations, has instilled confidence among investors, resulting in a rise in the stock price.
• The company's consistent cash generation and impressive track record of earnings have positioned it well amidst broader market uncertainties, such as concerns about increasing tariffs.
• While there have been some bearish movements in the options market, the overall sentiment towards CVS Health remains positive, with a significant portion of traders displaying bullish inclinations.
• The temporary halt by the FTC on a lawsuit involving CVS Health, Cigna, and UnitedHealth's PBMs may have offered some relief to investors, contributing to the stock's upward trend.

12.01.2025 - CVS Stock was up 17.4%

• CVS stock saw significant bullish movement recently.
• The uptrend followed an impressive Q4 earnings performance, surpassing both revenue and earnings projections.
• Bullish bets from market whales on CVS options added to the positive market sentiment.
• Investor confidence in CVS Health's growth outlook was strengthened by the appointment of a new CEO and positive expectations for FY25.

13.01.2025 - CVS Stock was up 5.1%

• Upbeat earnings were reported by CVS Health for the fourth quarter, surpassing sales expectations and leading to a positive outlook from analysts.
• The company foresees 10% earnings growth for 2025, primarily driven by Aetna's recovery, which further bolstered investor confidence.
• The positive trend in earnings and growth outlook in the healthcare sector, as exemplified by companies like Coca-Cola, Pepsi, and Walgreens Boots Alliance, likely contributed to CVS's strong bullish movement today.
• Analyst upgrades and a favorable earnings outlook for the healthcare industry as a whole may have also influenced the upward movement of CVS's stock price.

04.03.2025 - CVS Stock was down 6.3%

• The bearish movement in CVS stock today may have been influenced by actions of financial giants in the options market, leading to increased bearish sentiment among traders.
• Despite CVS Health surpassing earnings expectations, market sentiment could have been impacted by the FTC's decision to halt a lawsuit involving CVS, Cigna, and UnitedHealth's PBMs, creating uncertainty for investors.
• Geopolitical events, tariff concerns, and Federal Reserve indecision might have further fueled the bearish outlook on CVS stock, overshadowing its strong earnings track record.

04.03.2025 - CVS Stock was down 5.5%

• The decision to pause the lawsuit against CVS, Cigna, and UnitedHealth's PBMs may have raised concerns among investors about potential regulatory challenges for CVS.
• The absence of technology stocks in the list of best-performing S&P 500 stocks could have shifted investor focus away from healthcare companies like CVS, leading to a bearish movement in the stock.
• The market's reaction suggests that investors are closely monitoring regulatory developments and industry trends, contributing to the downward pressure on CVS stock today.